** Shares of medical diagnostics co Lantheus Holdings LNTH.O fall 20% to over 2-month low of $83.71
** Co forecast 2025 sales to be between $1.55 bln and $1.59 bln; analysts were expecting 2025 sales to be $1.59 bln - data compiled by LSEG
** Co forecast 2025 adj. EPS between $6.60 and $6.70; analysts were expecting it to be $7.08/shr
** Co posts Q1 sales of $372.8 mln, below analysts' est. of $379 mln
** Reports Q1 adj. profit of $1.53/shr, below est. of $1.66/shr
** Including session moves, stock down 7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.